Publications by authors named "Laura Hager"

Claim this Profile
T
Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users.
Nina Behle, Felicia Kamp, Lisa Proebstl, Laura Hager, Marlies Riebschläger

World J Psychiatry· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
App-based maintenance treatment for alcohol use disorder after acute inpatient treatment: Study protocol for a multicentre randomized controlled trial.
Sebastian Saur, Kiona K Weisel, Catharina Lang, Lukas M Fuhrmann, Sabine Steins-Loeber, Laura Hager

Internet Interv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalant Abuse of Ethyl Chloride Spray: A Case Report.
Laura Hager, Felicia Kamp, Lisa Proebstl, Nina Behle, Oliver Pogarell

Fortschr Neurol Psychiatr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence.
Lisa Proebstl, Daniela Krause, Felicia Kamp, Laura Hager, Kirsi Manz

Psychiatry Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between methamphetamine use, psychiatric comorbidities and treatment outcome in two inpatient rehabilitation centers.
Proebstl Lisa, Kamp Felicia, Hager Laura, Krause Daniela, Riebschläger Marlies

Psychiatry Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruthenium-arene complexes bearing naphthyl-substituted 1,3-dioxoindan-2-carboxamides ligands for G-quadruplex DNA recognition.
Laura A Hager, Stephan Mokesch, Claudia Kieler, Silvia Alonso-de Castro, Dina Baier

Dalton Trans· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Wojciech Streciwilk, Alessio Terenzi, Xinlai Cheng, Laura Hager, Yasamin Dabiri

Eur J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis